Bifogade filer
Sweden IR Strategic Update Jan 2026 EN
STOCKHOLM – Elekta (EKTA-B.ST) is pleased to invite investors, analysts, and other interested stakeholders to attend our Strategic Update on January 30, 2026. This digital event will provide a comprehensive update on Elekta’s strategic direction and ongoing innovation in precision radiation therapy. Presentations will feature Elekta’s President and CEO, Jakob Just-Bomholt, together with other members of Elekta’s executive leadership team, who will share insights into our latest advancements and future growth opportunities.
This is an excellent opportunity to engage directly with Elekta’s leadership, gain a deeper understanding of our commitment to sustainable, outcome-driven solutions, and learn how we continue to improve lives and bring hope to everyone dealing with cancer. We look forward to welcoming you to this important update.
To register for the online event, click this link.
Time: Friday, January 30, at 14:00 a.m. CET
# # #
For further information, please contact:
Peter Nyquist, Head of Investor Relations
Tel: +46 70 575 2906, e-mail: peter.nyquist@elekta.com
Time zone: CET (Central European Time)
About Elekta
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,500 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 40 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com.